Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 5/2012

01-05-2012 | Short Communication

A case of brucellar monoarthritis and review of the literature

Authors: Ethem Turgay Cerit, Murat Aydın, Alpay Azap

Published in: Rheumatology International | Issue 5/2012

Login to get access

Abstract

Brucellosis is a systemic infectious disease, which constitutes a public health problem in Turkey. Brucellosis has a broad spectrum of clinical manifestations. Osteoarthicular manifestations are often seen in brucellosis but most of the brucellar monoarthritis cases are reactive rather than being septic. We report a case of brucellar (septic) monoarthritis of the knee in a 74-year-old cattleman and review of the literature.
Literature
1.
Tanır G, Tufekci BS, Tuygun N (2009) Presentation, complications and treatment outcome of brucellosis in Turkish children. Pediatr Int 51(1):114–119PubMedCrossRef
2.
Memisoglu K, Yumuk Z, Akansel G (2008) An unusual presentation of brucellar septic arthritis involving the knee joint with extraarticular hardware: a case report. Knee 15(2):148–150PubMedCrossRef
3.
Al-Rawı ZS, Al-Khateeb N, Khalifa SJ (1987) Brucella arthritis among Iraqı patients. Br J Rheumatol 26(1):24–27PubMedCrossRef
4.
Khateeb MI, Araj GF, Majeed SA, Lulu AR (1990) Brucella arthritis: a study of 96 cases in Kuwait. Ann Rheum Dis 49:994–998PubMedCrossRef
5.
Kubler PA, Klestov AV (2001) Osteoarticular brucellosis with long latent period. Clin Rheumatol 20(6):444–446PubMedCrossRef
6.
Weil Y, Mattan Y, Liebergall M, Rahav G (2003) Brucella prosthetic joint infection; a report of 3 cases and a review of the literature. Clin Infect Dis 36(7):81–86CrossRef
7.
Duyur B, Erdem HR, Ozgocmen S (2001) Paravertebral abscess formation and knee arthritis due to brucellosis in a patient with rheumatoid arthritis. Spinal Cord 39:554–556PubMedCrossRef
8.
Tassinari E, Di Motta D, Giardina F et al (2008) Brucella infection in total knee arthroplasty, case report and revision of the literature. Chir Organi Mov 92:55–59PubMedCrossRef
9.
Agarwall S, Kadhi SK, Rooney RJ (1991) Brucellosis complicating bilateral total knee arthroplasty. Clin Orthop Relat Res 267:179–181
10.
Malizoc KN, Maleris CA, Soucacos PN (1997) Total knee arthroplasties infected by Brucella melitensis: a case report. Am J Orthop 26(4):283–285
11.
Orti A, Roig P, Akala R et al (1997) Brucellar prosthetic arthritis in a total knee replacement. Eur J Clin Microbiol Infect Dis 16(11):843–845PubMedCrossRef
12.
Andonopoulos AP, Asımakopoulos G, Anastasiou E, Bassaris HP (1986) Brucella arthritis. Scand J Rheumatol 15(4):377–380PubMedCrossRef
13.
Yagupsky P, Peled N, Pres J (2001) Use of BACTEC 9240 blood culture system for detection of B. melitensis in synovial fluid. J Clin Microbiol 39(2):738–739PubMedCrossRef
14.
Solera J, Martinez-Alfaro E, Espinosa A (1997) Recognition and optimum treatment of brucellosis. Drugs 53(2):245–256PubMedCrossRef
15.
Ayaslıoglu N, Ozluk O, Kılıç D et al (2005) A case of brucellar septic arthritis of the knee with a prolenged clinical course. Rheumatol Int 25(1):69–71PubMedCrossRef
16.
Hashemi SH, Keramat F, Ranjbar M et al (2007) Osteoarticular complications of brucellosis in Hamedan, an endemic area in the west of Iran. Int J Infect Dis 11(6):496–500PubMedCrossRef
17.
Eder L, Zisman D, Rozenbaum M, Rosner I (2005) Clinical features and aetiology of septic arthritis in northern Israel. Rheumatology 44(12):1559–1563PubMedCrossRef
18.
Palanduz A, Telhan L, Yıldırmak Y et al (2005) Brucellar arthritis of the knee in a child. J Paediatr Child Health 41(1–2):76–77PubMedCrossRef
19.
Metadata
Title
A case of brucellar monoarthritis and review of the literature
Authors
Ethem Turgay Cerit
Murat Aydın
Alpay Azap
Publication date
01-05-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 5/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-1917-8

Other articles of this Issue 5/2012

Rheumatology International 5/2012 Go to the issue

Original Article

Interleukin-23 receptor genetic polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis

Original Article

Power Doppler ultrasonography is useful for assessing disease activity and predicting joint destruction in rheumatoid arthritis patients receiving tocilizumab—preliminary data

Original Article

Involvement of soluble receptor activator of nuclear factor-κB ligand (sRANKL) in collagenase-induced murine osteoarthritis and human osteoarthritis

Short Communication

Atypical presentation of Behçet’s disease with central nervous system involvement successfully treated with infliximab

Original Article

Long-term efficacy of anti-CD20 antibodies in refractory lupus nephritis

Short Communication

Unusual presentation of sarcoidosis in a child
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits